Rang	Name	Position
1	Mr. David P. Hochman	Founder, Chairman of the Board of Directors & CEO
2	Mr. Darren R. Sherman	Founder, President, COO & Director
3	Mr. Andrew Lawrence Taylor M.B.A.	Chief Financial Officer
4	Mr. William Reed Little	Executive Vice President of Corporate Development & Strategy
5	Ms. Lisa Daniels	Vice President of Human Resources
6	Dr. Yuval Hay Mika D.Sc, Ph.D.	GM & CTO of Bioelectronic Therapies
7	Dr. Hans-Peter Stoll M.D., Ph.D.	Senior VP & Medical Director
8	Dr. Avraham Matityahu Fischer M.D.	Senior Vice President of Medical Affairs & Innovation
9	Mr. Bob Laughner	Senior Vice President of Regulatory & Quality
10	Mr. Juan Lorenzo	Senior Vice President of Product Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RTW INVESTMENTS, LLC	13,82%	50,83 Mio. USD
2	Perceptive Advisors LLC	8,38%	30,83 Mio. USD
3	Vanguard Capital Management, LLC	3,67%	13,49 Mio. USD
4	Alyeska Investment Group, L.P.	1,66%	6,12 Mio. USD
5	Propel Bio Management LLC	1,49%	5,49 Mio. USD
6	BlackRock Inc	1,06%	3,89 Mio. USD
7	Geode Capital Management, LLC	0,81%	2,97 Mio. USD
8	Rice Hall James & Associates, LLC	0,71%	2,60 Mio. USD
9	Charles Schwab Investment Management Inc	0,44%	1,63 Mio. USD
10	Knott David M Jr	0,42%	1,55 Mio. USD
11	Vanguard Fiduciary Trust Co	0,39%	1,44 Mio. USD
12	Simplify Asset Management Inc.	0,37%	1,34 Mio. USD
13	Marshall Wace Asset Management Ltd	0,31%	1,15 Mio. USD
14	683 Capital Management LLC	0,31%	1,13 Mio. USD
15	State Street Corp	0,28%	1,04 Mio. USD
16	The Goldman Sachs Group Inc	0,26%	0,95 Mio. USD
17	Dafna Capital Management LLC	0,21%	0,78 Mio. USD
18	Northern Trust Corp	0,20%	0,72 Mio. USD
19	Qube Research & Technologies	0,18%	0,67 Mio. USD
20	Susquehanna International Group, LLP	0,16%	0,60 Mio. USD